NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Total Current Liabilities

As of the most recent data (December 2025), NRSNW shows a total current liabilities of $2.5M. That compares with $2M in the prior-year period — up 26.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRSNW's total current liabilities is now $2.5M (was $2M) — a 26.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NeuroSense Therapeutics Ltd - Warrants (09/11/2026) is outperforming or lagging.

Tracking NRSNW's total current liabilities over time shows whether NeuroSense Therapeutics Ltd - Warrants (09/11/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5M That compares with $2M in the prior-year period — up 26.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $2.5M) with ownership activity and broader fundamentals.